Skip to main content

Advertisement

Table 1 Basic characteristics of the subjects

From: Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration

  RBC (X104/μL) Platelets (X104/μL) alb (mg/dL) HDL-C (mg/dL) LDL-C (mg/dL) TG (mg/dL) ATX (ng/mL)
AA 215.0 ± 9.9* 2.8 ± 0.5 4.4 ± 0.1 54.8 ± 14.6 103.6 ± 35.4 178.5 ± 200.1 1.49 ± 0.39
ET 467.9 ± 101.2 84.8 ± 35.4† 4.2 ± 0.2 56.8 ± 14.4 104.5 ± 40.4 144.7 ± 66.5 0.96 ± 0.13
ITP 472.2 ± 40.1 3.1 ± 1.1 4.1 ± 0.4 57.9 ± 15.7 100.9 ± 25.9 164.2 ± 127.3 0.96 ± 0.13
VWD 423.0 ± 89.9 27.5 ± 6.3 4.4 ± 0.2 28.9 ± 0.4 73.9 ± 59.9 127.7 ± 29.6 0.95 ± 0.12
NHD 436.4 ± 71.8 22.1 ± 8.2 4.1 ± 0.5 40.3 ± 19.0 127.4 ± 53.5 135.7 ± 71.7 0.90 ± 0.07
All 437.3 ± 86.6 31.2 ± 31.1 4.1 ± 0.4 45.1 ± 18.9 116.0 ± 49.6 140.3 ± 78.7 0.95 ± 0.05
  1. Serum samples were collected from subjects with NHD (non-hematological disorders, n=33) and patients with AA (aplastic anemia, n=2), ET (essential thrombocythemia, n=10), ITP (idiopathic thrombocytopenia purpura, n=6), and VWD (von Willebrand diseases, n=3). ATX represents autotaxin. Data were shown as the mean ± SD.
  2. * P<0.01 vs. ET, ITP, NHD, and P<0.05 vs. VWD; †P<0.01 vs. the other groups.